We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

200 hedge funds and large institutions have $1.07B invested in Heron Therapeutics in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 57 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

21% more call options, than puts

Call options by funds: $12.5M | Put options by funds: $10.4M

16% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 57

8.95% more ownership

Funds ownership: 106.46% → 115.41% (+9%)

2% more funds holding

Funds holding: 197 → 200 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less capital invested

Capital invested by funds: $1.16B → $1.07B (-$87.7M)

Holders
200
Holders Change
+3
Holders Change %
+1.52%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
32
Increased
66
Reduced
57
Closed
26
Calls
$12.5M
Puts
$10.4M
Net Calls
+$2.14M
Net Calls Change
+$80K

Top Buyers

1
UOC
UBS O'Connor
Illinois
+$16.8M
2
Citadel Advisors
Citadel Advisors
Florida
+$15.8M
3
State Street
State Street
Massachusetts
+$12.3M
4
Millennium Management
Millennium Management
New York
+$10.3M
5
SCM
Suvretta Capital Management
New York
+$10.2M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$17.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.01M
3
GLA
Great Lakes Advisors
Illinois
-$7.94M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.24M
5
PAM
Panagora Asset Management
Massachusetts
-$4.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
201
SG Americas Securities
New York
– -$444K -41,535 Closed
XT
202
XTX Topco
Cayman Islands
– -$287K -26,811 Closed
DCM
203
Dupont Capital Management
Delaware
– -$226K -21,153 Closed
TC
204
TwinBeech Capital
New York
– -$194K -18,167 Closed
RJA
205
Raymond James & Associates
Florida
– -$151K -14,081 Closed
IWM
206
IHT Wealth Management
Illinois
– -$129K -12,025 Closed
Voloridge Investment Management
207
Voloridge Investment Management
Florida
– -$128K -11,933 Closed
EGM
208
Engineers Gate Manager
New York
– -$118K -11,006 Closed
Truist Financial
209
Truist Financial
North Carolina
– -$109K -10,226 Closed
NFSG
210
Newbridge Financial Services Group
Florida
– -$73K -6,860 Closed
PHK
211
Point72 Hong Kong
Hong Kong
– -$73K -6,787 Closed
S
212
SignatureFD
Georgia
– -$64K -6,028 Closed
TLCM
213
Twin Lakes Capital Management
California
– -$45K -4,170 Closed
RFA
214
Reilly Financial Advisors
California
– -$43K -4,000 Closed
IF
215
Ironwood Financial
Arizona
– -$31K -2,927 Closed
HI
216
Harbour Investments
Wisconsin
– -$13K -1,188 Closed
GWM
217
Geneos Wealth Management
Colorado
– -$7K -704 Closed
CFA
218
Cahill Financial Advisors
Minnesota
– -$2K -223 Closed
GWS
219
Glassman Wealth Services
Virginia
– -$2K -162 Closed
JMF
220
Johnson Midwest Financial
Iowa
– -$2K -155 Closed
AF
221
Allworth Financial
California
– -$2K -150 Closed
RE
222
RBC Europe
United Kingdom
– -$1.28K -120 Closed
CI
223
Cordant Inc
Oregon
– -$1K -63 Closed
QCG
224
Quadrant Capital Group
Ohio
– +$531 +52 New
5 6 7 8
9

HRTX Hedge Fund Activity: Q4 2021 in Review

200 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2021, worth a combined $1.07B — down 7.6% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new HRTX positions and 26 closed out — a net gain of 6 holders — while 66 added to existing stakes and 57 trimmed.

The largest buyer was UBS O'Connor, adding an estimated $16.8M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $17.1M sold.

  • 200 institutional investors held Heron Therapeutics (HRTX) as of Q4 2021, up from 197 in Q3 2021.
  • Funds reported $1.07B of Heron Therapeutics stock for Q4 2021, down 7.6% quarter-over-quarter.
  • 32 funds opened new Heron Therapeutics positions in Q4 2021 and 26 closed out, a net change of +6 holders.
  • The largest Heron Therapeutics buyer in Q4 2021 was UBS O'Connor, an estimated $16.8M added.
  • The largest Heron Therapeutics seller in Q4 2021 was Point72 Asset Management, an estimated $17.1M sold.

Based on aggregated 13F filings for Q4 2021.